1-H-indole-3-carboxylic acid, trans-octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester,
MDL 74156,
MDL-74156,
Mdl 74156,
Hydrodolasetron,
127951-99-9,
Mdl-74156,
1H-Indole-3-carboxylicacid, octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester,
1H-Indole-3-carboxylic acid, octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester,
1-H-Indole-3-carboxylic acid, trans-octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester,
ACMC-20msnw,
AC1L4LYC,
AC1Q60Y9,
CHEMBL498572,
SCHEMBL7281981,
CTK4B5810,
BDBM50412171,
10-hydroxy-8-azatricyclo[5.3.1.03,8]undec-5-yl 1h-indole-3-carboxylate,
AKOS030254922,
LS-172694,
J-005559,
1H-Indole-3-carboxylic acid (octahydro-3-hydroxy-2,6-methano-2H-quinolizine)-8-yl ester,
1H-Indole-3-carboxylic acid, octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl,
Reduced Dolasetron,
Chlorine oxide (clo),
Cl-O,
UNII-YC09CA0VBB,
D01IWD,
C19H22N2O3,
AR-1C0217,
AR-1C0218,
CID159502,
C19-H22-N2-O3,
14989-30-1,
14989-29-8,